Coordinating Multi-Jurisdiction Recalls in 2026: FDA, CPSC, Health Canada, and TGA Working in Parallel

A practical operating model for executing the same recall simultaneously across the United States, Canada, Australia, and the European Union.

Why a Single-Jurisdiction Playbook Is No Longer Enough

For brands selling globally, the moment a serious product defect is confirmed is the moment a single internal incident becomes multiple regulatory events — one in each market where the affected product was distributed. In the United States, the relevant regulator might be FDA, CPSC, NHTSA, USDA-FSIS, or EPA depending on the product category. In Canada, Health Canada or CFIA. In Australia, the TGA, the ACCC, or Food Standards Australia New Zealand. In the EU, member-state market surveillance authorities under the framework set by the General Product Safety Regulation, and category-specific regulators where they apply.

Each of these regulators has its own notification window, its own preferred classification system, its own evidence expectations, and its own communication protocol. The temptation — and the pattern that creates the most operational damage in the field — is to treat each jurisdiction as a parallel but independent recall. That model fails for three reasons:

1. Notification windows are not aligned. A delay in one jurisdiction creates compounding pressure in others, especially as international regulatory intelligence sharing has matured (a trend we covered in our Q1 2026 product recall intelligence report).
2. Inconsistent communication is itself a regulatory risk. Different consumer messages in different markets — particularly when surfaced together by the trade press, social media, or comparative regulator review — create credibility damage and follow-on regulator scrutiny.
3. Evidence and classification work cannot be efficiently duplicated. The investigation, root cause analysis, and risk assessment work that supports a recall in one jurisdiction is, with appropriate adaptation, the same work that supports the recall in every other jurisdiction. Duplicating it is wasteful; failing to adapt it is dangerous.

What follows is a practical operating model for running multi-jurisdiction recalls as a single coordinated operation rather than parallel independent ones — and the platform capabilities that hold the model together.

The Operating Model in One Picture

A coordinated multi-jurisdiction recall has five workstreams running simultaneously, governed by a single decision-making structure:

1. Investigation and evidence — root cause analysis, hazard characterisation, scope determination, traceability reconstruction.
2. Classification mapping — translating one set of facts into the classification language each regulator uses.
3. Notification execution — meeting each jurisdiction's notification window with jurisdiction-appropriate documentation.
4. Communications consistency — ensuring consumer-facing, channel-facing, and press messaging is coherent across markets.
5. Action tracking and disposition — quantity recovered, quantity disposed, return rates, retailer compliance, and regulator follow-up commitments — by jurisdiction and in aggregate.

Above all five, a single incident command function owns the decisions, the timeline, and the audit trail. Below all five, a single system of record holds the evidence and the activity log that everyone is working from.

Notification Window Mismatches and How to Manage Them

The most operationally consequential difference across jurisdictions is the notification window — the period within which the manufacturer must report a reportable event to the relevant authority once the threshold is met.

United States — FDA (drug, food, device, cosmetic). Reporting requirements vary by product category, but for medical devices the 21 CFR 803 Medical Device Reporting framework requires reports of certain events within 30 calendar days, and within five working days for events requiring remedial action to prevent unreasonable risk. For drugs, 21 CFR 314.81 field alert reports require notification within three working days. For foods, the Reportable Food Registry under FSMA requires notification within 24 hours of determining a reportable food event.

United States — CPSC. Section 15(b) of the Consumer Product Safety Act requires immediate notification — interpreted by CPSC as within 24 hours — once a manufacturer obtains information reasonably supporting the conclusion that a product fails to comply with applicable rules, contains a defect that could create a substantial product hazard, or creates an unreasonable risk of serious injury or death.

Canada — Health Canada and CFIA. Under the Canada Consumer Product Safety Act, manufacturers, importers, and sellers must report incidents involving consumer products to Health Canada within two days of becoming aware. Under the Safe Food for Canadians Act, food incidents must be reported to CFIA within timeframes specified by the regulation and category. Health Canada's medical device reporting requires manufacturers to submit reports within 10 calendar days for events requiring action to prevent serious deterioration in health, and within 30 days for other reportable events.

Australia — TGA and ACCC. TGA reporting requirements for medical devices include 48-hour, 10-day, and 30-day windows depending on the event severity. Mandatory reporting of consumer goods incidents under the Australian Consumer Law requires notification to the ACCC within two days of becoming aware that a person has died, suffered serious injury or illness, or that the product was used in a way it was not intended to be used.

European Union — GPSR and category regulators. Under GPSR, economic operators must notify the relevant national authorities without delay where they know or have reason to believe that a product they have placed on the market presents a risk that is incompatible with the general safety requirement. Category regulators — including for medical devices under EU MDR and pharmaceuticals under the centralised and decentralised procedures — have their own notification frameworks layered on top.

The practical reality of this map is that the shortest notification window in any affected jurisdiction effectively becomes the global timeline. Once internal evidence supports a CPSC Section 15(b) report — 24 hours — the company has 24 hours to also have its FDA, Health Canada, TGA, and EU notifications in motion, even where their formal windows are longer. Trying to manage these windows independently produces precisely the staggered, inconsistent notification pattern that regulators increasingly view with suspicion.

Classification Mapping Across Jurisdictions

Each major recall jurisdiction uses its own classification system. The same factual recall is typically:

• FDA Class I, Class II, or Class III based on health consequence severity.
• CPSC substantial product hazard based on the unreasonable risk of injury or death from a defect or failure to comply.
• Health Canada Type I, Type II, or Type III for drug recalls; risk-based for consumer products.
• TGA Class I or Class II for medical devices, with separate frameworks for therapeutic goods and consumer products.
• EU GPSR serious risk or non-serious risk classifications, with category-specific frameworks under EU MDR, the Toy Safety Directive, REACH, and other category regulators.

These classifications are not isomorphic — a Class I FDA recall does not automatically map one-to-one to a Class I Health Canada recall — but the underlying facts and risk assessment they rely on are common. Best-practice incident command teams maintain a classification crosswalk for their categories, owned by a regulatory affairs lead, that translates the common evidence base into each regulator's classification language without re-running the underlying analysis.

The classification crosswalk is a living document. It needs to be reviewed against each regulator's published guidance at least annually and updated whenever any of the underlying frameworks change.

Evidence Package Re-Use

The investigation work that supports a recall — adverse event analysis, complaint trending, root cause investigation, risk assessment, scope determination, traceability reconstruction — is roughly 70-80% common across jurisdictions. The remaining 20-30% is jurisdiction-specific framing: the format of the regulatory submission, the specific evidence the regulator expects to see, and the language used to describe the risk.

Operating teams that treat the common 70-80% as a shared evidence package, with jurisdiction-specific addenda layered on top, dramatically reduce the duplication of effort and the inconsistency risk that comes from independently produced submissions in different jurisdictions.

The evidence package needs a single owner — typically the quality director or senior regulatory affairs lead — who is responsible for keeping the underlying facts, the analysis, and the conclusions aligned across every jurisdiction's submission. The owner does not have to write every submission, but every submission has to be consistent with the owner's evidence package.

Communications Consistency

In a multi-jurisdiction recall, three communication audiences need coordinated messaging:

1. Regulators — formal submissions, follow-up correspondence, and on-site engagement.
2. Trade and channel partners — distributors, retailers, healthcare providers, and other commercial intermediaries.
3. Consumers and the public — direct notifications, press communications, social media, and the company's own digital channels.

Inconsistencies across these audiences create exactly the credibility damage that compounds a recall's commercial impact. A consumer notification in one market that uses a more reassuring tone than the equivalent in another market will, in the current information environment, be surfaced and compared within hours. The discipline is to write a single core message, validated against the evidence package, and adapt it for each jurisdiction without softening or strengthening the substance.

A practical guideline: any comparative claim in a consumer notification ("affects only X% of units," "no injuries reported," "out of an abundance of caution") needs to be either true in every market the message reaches or scoped explicitly to the market it applies to. Otherwise it should not be in the message.

Action Tracking and Disposition

A multi-jurisdiction recall produces a stream of action data: units returned, units disposed, retailer compliance with stop-sell orders, replacement product distributed, refund volume processed, regulator follow-up commitments closed. This data needs to flow into a single tracking surface, sliced by jurisdiction but aggregated for executive and regulator-level reporting.

Brands that maintain this data in jurisdiction-specific spreadsheets — one in the US team's drive, another in the EU compliance lead's drive — invariably find that aggregated reporting becomes painful, that month-end inconsistencies are common, and that providing a global picture to a board or an audit committee requires a multi-day reconciliation exercise. The right answer is a recall management platform that holds the action data centrally, with jurisdiction-aware views.

What Platform Capabilities Actually Hold This Together

Running this operating model under pressure requires a small set of platform capabilities that hang together:

• Multi-jurisdiction monitoring — coverage of the regulatory databases and alert systems for every market the brand sells into. SuperRecall.ai monitors 44+ regulatory databases including FDA, CPSC, NHTSA, USDA-FSIS, Health Canada, CFIA, TGA, ACCC, EU Safety Gate, and the major member-state surveillance authorities.
• Single audit log — a tamper-evident record of who saw what signal when, who decided what, and who took what action — with role-based access control that allows distributed teams to operate in their own swim lanes without losing the central record.
• Workflow templates with jurisdiction overlays — the common investigation and decision workflow runs once, with jurisdiction-specific notification, classification, and action steps layered on top.
• Evidence and document management — central storage of the evidence package and the jurisdiction-specific submissions, with version control and signature audit trail.
• Action tracking and reporting — central dashboards that aggregate jurisdiction-specific action data into a single executive view.

This is the kind of capability profile we have built SuperRecall.ai around. For brands operating across multiple major markets, the platform is designed to be the system of record under which a multi-jurisdiction recall can be run as a single coordinated operation rather than parallel independent ones. We compare the capability set against the alternatives in our best product recall software comparison, and walk through the global regulatory framework in detail in our global recall regulations comparison guide.

Closing Note

The companies that handle their next multi-jurisdiction recall well will not be the companies with the most resources. They will be the companies that prepared a coordinated operating model in advance, that maintained their classification crosswalks and trading-partner data continuously, and that operated from a single system of record under pressure. None of this is conceptually difficult. All of it is unglamorous, ongoing work that pays back the moment an incident command is stood up.

If your team would like to walk through your own multi-jurisdiction recall readiness with us — using your category, your distribution footprint, and your existing tooling as the starting point — book a working session or contact our team at sales@superrecall.ai, and we will run through the operating model against a realistic scenario.